Cargando…
The CRISPR/Cas9 System Delivered by Extracellular Vesicles
Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) systems can precisely manipulate DNA sequences to change the characteristics of cells and organs, which has potential in the mechanistic research on genes and the treatment of diseases. However, clinica...
Autores principales: | Zhu, Xinglong, Gao, Mengyu, Yang, Yongfeng, Li, Weimin, Bao, Ji, Li, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053467/ https://www.ncbi.nlm.nih.gov/pubmed/36986843 http://dx.doi.org/10.3390/pharmaceutics15030984 |
Ejemplares similares
-
Engineered Extracellular
Vesicle-Delivered CRISPR/Cas9
for Radiotherapy Sensitization of Glioblastoma
por: Liu, Xiao, et al.
Publicado: (2023) -
Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy
por: Zhuang, Jialang, et al.
Publicado: (2020) -
Engineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing Tool
por: Li, Tianwen, et al.
Publicado: (2023) -
CRISPR-Cas9 delivery strategies with engineered extracellular vesicles
por: Lu, Yaoyao, et al.
Publicado: (2023) -
In Vivo Visualized Tracking of Tumor-Derived
Extracellular Vesicles Using CRISPR-Cas9 System
por: Ye, Yangyang, et al.
Publicado: (2022)